Infectious Disease
414 FDA-approved drugs
Recent Approvals
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE
EMTRICITABINE
BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1...
2026-01-30
Apotex
RILPIVIRINE HYDROCHLORIDE
RILPIVIRINE HYDROCHLORIDE
human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 2 y...
2026-01-29
SOMERSET THERAPS LLC
DALBAVANCIN HYDROCHLORIDE
DALBAVANCIN HYDROCHLORIDE
adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused...
2025-10-23
Fresenius Kabi
CONTEPO
FOSFOMYCIN DISODIUM
patients 18 years of age and older with complicated urinary tract infections (cUTI) including acute ...
2025-10-22
MEITHEAL
CLOTIC
CLOTRIMAZOLE
Uses Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis)...
2025-09-26
CARWIN PHARM ASSOC
YEZTUGO
LENACAPAVIR
pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolesce...
2025-06-18
Gilead Sciences
EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE
EMTRICITABINE
use as a complete regimen for the treatment of HIV-1 infection in patients weighing at least 35 kg (...
2025-05-20
Viatris
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and old...
2025-04-03
B BRAUN MEDICAL
BLUJEPA
GEPOTIDACIN MESYLATE
the following infections caused by susceptible microorganisms: • Uncomplicated urinary tract infecti...
2025-03-25
GSK
EMBLAVEO
AVIBACTAM SODIUM
EMBLAVEO is a combination of aztreonam, a monobactam antibacterial, and avibactam, a beta-lactamase ...
2025-02-07
AbbVie
ORLYNVAH
PROBENECID
uncomplicated urinary tract infections (uUTI) caused by the designated microorganisms Escherichia co...
2024-10-25
ITERUM THERAP
XOLREMDI
MAVORIXAFOR
XOLREMDI is indicated in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglob...
2024-04-26
X4 PHARMS
PIVYA
PIVMECILLINAM HYDROCHLORIDE
female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused ...
2024-04-24
ALEMBIC THERAP
ZEVTERA
CEFTOBIPROLE MEDOCARIL SODIUM
adult patients with Staphylococcus aureus bloodstream infection (bacteremia) (SAB), including those ...
2024-04-03
ISTX
EDURANT PED
RILPIVIRINE HYDROCHLORIDE
human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 2 y...
2024-03-15
Johnson & Johnson
REZDIFFRA
RESMETIROM
REZDIFFRA is indicated in conjunction with diet and exercise for the treatment of adults with noncir...
2024-03-14
MADRIGAL
FIDAXOMICIN
FIDAXOMICIN
Fidaxomicin tablets are a macrolide antibacterial indicated in adult patients for the treatment of C...
2024-01-16
Apotex
DEFENCATH
HEPARIN SODIUM
use in a limited and specific population of patients [see Clinical Studies (14) ]...
2023-11-15
CORMEDIX
FACTOR XATHROMBIN
CABTREO
ADAPALENE
the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older...
2023-10-20
BAUSCH
MICAFUNGIN IN SODIUM CHLORIDE 0.9%
MICAFUNGIN SODIUM
Micafungin for injection is indicated for: Treatment of Candidemia, Acute Disseminated Candidiasis, ...
2023-09-29
Baxter
Showing 20 of 414 drugs
Top Companies
Drug Classes
Azole Antifungal 11
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor 10
Nitroimidazole Antimicrobial 10
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 8
Cytochrome P450 3A Inhibitor 7
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor 6
Aminoglycoside Antibacterial 6
Nitrofuran Antibacterial 5
Rifamycin Antimycobacterial 4
Protease Inhibitor 4
Quick Stats
- Total Drugs
- 414
- Companies
- 152
- Drug Classes
- 61
- Latest Approval
- 2026-01-30